Finally, corroborative work by our group revealed that TLR7 agonism accelerates both local and systemic disease in a mouse model of pSD and drives the expansion of a subset of B cells that are pathogenic in the context of lupus, termed age-associated B cells or ABCs (50). Here, TLR7 is linked to systemic lupus erythematosus.